fda declares semaglutide shortage resolved february 2025 says Wegovy and Ozempic resolved; Hims & Hers stock falls Shortage of popular weight-loss and

PlexusDx's licensed 503A compounding pharmacies can restart you on compounded semaglutide within days of your first consultationno waiting for FDA pharmacy shipments

Longevity support

As GLP-1 receptor agonists gain wider use for metabolic disease and weight management, dermatologists, primary care clinicians, researchers, and patients are seeking clear information about possible cutaneous effects, rare adverse events, and potential therapeutic interactions

CagriSema is Novos next-generation obesity drug candidate, still in clinical trials so not available to the public

Nikita took the time to listen to my concerns and thoroughly assess my condition